Curated News:

National Institute of Allergy and Infectious Diseases (NIAID)

Add to Favorites Subscribe Share
fbshare-National Institute of Allergy and Infectious Diseases (NIAID)

Showing results

110 of 10
Newswise: Influenza IMPRINT Cohort Study Receives Funding Boost

Influenza IMPRINT Cohort Study Receives Funding Boost

Cincinnati Children's Hospital Medical Center

The Influenza IMPRINT Cohort study will explore the emerging idea that a person’s very first influenza virus exposure impacts the magnitude, durability and breadth of their immune response to all future flu exposures.

Channels: All Journal News, Children's Health, Immunology, Infectious Diseases, Microbiome, Vaccines, Influenza, National Institute of Allergy and Infectious Diseases (NIAID),

Released:
10-Dec-2019 7:30 AM EST
Newswise: Research at Argonne's Advanced Photo Source Leads to New Ebola Drug

Research at Argonne's Advanced Photo Source Leads to New Ebola Drug

Argonne National Laboratory

Scientists using specialized beamlines at Argonne's Structural Biology Center (SBC), a facility for macromolecular crystallography at the Advanced Photon Source, derived insights that led to the discovery of a promising new drug for Ebola.

Channels: All Journal News, Clinical Trials, DOE Science News, Infectious Diseases, Pharmaceuticals, Vaccines, Ebola, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), DOE Science News,

Released:
9-Dec-2019 2:45 PM EST
Announcement
  • Embargo expired:
    5-Dec-2019 11:00 AM EST

More Than a Watchdog

Harvard Medical School

Study in mice shows the nervous system not only detects the presence of Salmonella in the gut but actively stops the organism from infecting the body Nerves in the gut prevent Salmonella infection by shutting the cellular gates that allow bacteria to invade the intestine and spread beyond it As a second line of defense, gut neurons help avert Salmonella invasion by maintaining the levels of key protective microbes in the gut Findings reveal prominent role for nervous system in infection protection and regulation of immunity

Channels: All Journal News, Digestive Disorders, Immunology, Infectious Diseases, Microbiome, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Cell (journal),

Released:
2-Dec-2019 2:45 PM EST
Feature
Newswise: Early immune response may improve cancer immunotherapies

Early immune response may improve cancer immunotherapies

University of Illinois at Chicago

In a paper published in the Journal of Biological Chemistry, University of Illinois at Chicago researchers and colleagues report a new mechanism for detecting foreign material during early immune responses.

Channels: All Journal News, Cancer, Chemistry, Immunology, National Institute of Allergy and Infectious Diseases (NIAID),

Released:
3-Dec-2019 11:55 AM EST
Research Results

Duke Vaccine Institute Plays Integral Role in National Effort to Improve Flu Shots

Duke Clinical Research Institute

As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases (NIAID), with an initial award of approximately $29.6 million in first-year funding.

Channels: AIDS and HIV, Immunology, Infectious Diseases, Public Health, Respiratory Diseases and Disorders, Vaccines, Influenza, National Institute of Allergy and Infectious Diseases (NIAID),

Released:
30-Sep-2019 11:05 AM EDT
Announcement
UM_School_Medicine.png

UM School of Medicine’s Center for Vaccine Development and Global Health Receives NIH Contract for Influenza Research

University of Maryland School of Medicine

The National Institute of Allergy and Infectious Diseases research contract is one of the largest ever awarded to UMSOM and includes an initial award of approximately $2.5 million to conduct clinical testing of influenza vaccines. Total funding over seven years could be as much as $201 million if all options are exercised in the NIAID contract.

Channels: Children's Health, Infectious Diseases, Vaccines, Influenza, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), All Journal News,

Released:
20-Sep-2019 2:05 PM EDT
Feature
Newswise: Starting HIV Treatment in ERs May Be Key to Ending HIV Spread Worldwide

Starting HIV Treatment in ERs May Be Key to Ending HIV Spread Worldwide

Johns Hopkins Medicine

In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease. A report on the findings was published in August in EClinicalMedicine.

Channels: AIDS and HIV, All Journal News, Emergency Medicine, Infectious Diseases, Public Health, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH),

Released:
16-Sep-2019 10:05 AM EDT
Announcement

Showing results

110 of 10

Chat now!
0.99765